Back to results
US 2024/0226263 A1Published application
Peptides derived from acinetobacter baumannii and their use in vaccination
AssigneeEvaxion Biotech A/S
InventorsNiels Iversen Møller, Andreas Holm Mattson
Life of this patent
Estimating the term…
Abstract
The present invention relates to proteins derived from Acinetobacter baumanii, nucleic acids encoding the proteins, antibodies specific for the proteins as well as methods of therapy, prophylaxis, and diagnosis that utilise the proteins, nucleic acids, and antibodies.
Claims26
A pharmaceutical composition comprising a polypeptide, said polypeptide comprising
- a) an amino acid sequence selected from the group consisting of SEQ ID NO:
- 18 and a fragment of SEQ ID NO:
- 18 comprising at least 35 contiguous amino acids of SEQ ID NO:
- 18, or
- c) an amino add sequence having a sequence identity of at least 60% with the amino add sequence of a),
- in admixture with an immunological adjuvant and a pharmaceutically acceptable carrier, vehicle or diluent,
- said polypeptide being antigenic in a mammal.
4 more elements
Dependencies are inferred from the claim text.